Jane Street
PDSB icon

Jane Street’s PDS Biotechnology PDSB Stock Holding History

Jane Street’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27,900
Closed -$140K – 9182
2023
Q2 		$140K Buy
+27,900
New +$183K ﹤0.01% 7846
2023
Q1 		– Sell
-25,200
Closed -$333K – 9699
2022
Q4 		$333K Buy
+25,200
New +$178K ﹤0.01% 6845
2021
Q4 		– Sell
-19,600
Closed -$292K – 10634
2021
Q3 		$292K Buy
+19,600
New +$244K ﹤0.01% 8247

Other funds holding PDSB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's PDSB Position: Q4 2025 in Review

Jane Street sold out of PDS Biotechnology (PDSB) in Q4 2025, closing a stake of 36,581 shares — an estimated $36.9K sold.

Jane Street first reported a position in PDSB in Q2 2018 and held it in 14 quarters. The position peaked at $762K in Q1 2023. 44 funds tracked by Wall St. Rank hold PDSB as of Q4 2025.

  • Jane Street reported no remaining PDS Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 36,581 PDS Biotechnology shares in Q4 2025, an estimated $36.9K.
  • Jane Street first reported a position in PDS Biotechnology in Q2 2018 and held it in 14 quarters.
  • Jane Street's PDS Biotechnology position peaked at $762K in Q1 2023.
  • 44 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.